Heron Therapeutics, Inc. Reaffirms Earnings Guidance for the Full Year 2026

Published: 2026-05-11 11:52:21 ET HRTX

Published on 05/11/2026 at 11:52 am EDT

Heron Therapeutics, Inc. reaffirmed earnings guidance for the full year 2026. For the period, the company expects net revenue of $173?$183 million.